---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058888"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:31:22.458882+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences prices $2.6M public offering of 1.05M shares at $2.50 each

## Summary
- Offering of 1,054,604 shares closed on June 9, 2025; gross proceeds ~$2.6M.
- Proceeds to fund general corporate purposes, including expenses for Vyome merger and asset sale to Ninjour.
- Maxim Group LLC acted as sole placement agent; receives 7% cash fee and warrants for 52,730 shares at $2.75.
- Shares sold at $2.50 per share; shelf registration filed May 2025 and declared effective May 14, 2025.

## SEC filing metadata
- accession: 0001104659-25-058888
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925058888/0001104659-25-058888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925058888/tm2517509d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058888
- JSON: https://secwatch.observer/filing/0001104659-25-058888.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058888.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.